BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 1777616)

  • 1. [Role of gastric mucosa prostaglandins in the development of ulcer lesions in liver cirrhosis].
    Vysotskaia RA; Loginov AS; Kondashova ZD
    Biull Eksp Biol Med; 1991 Dec; 112(12):588-90. PubMed ID: 1777616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stomach mucosa prostaglandins in liver cirrhosis].
    Vysotskaia RA; Loginov AS; Kondashova ZD; Kuznetsov AS; Varvanina GG; Grushetskaia OO
    Vopr Med Khim; 1992; 38(1):26-8. PubMed ID: 1441288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin and protection of the gastroduodenal mucosa.
    Johansson C; Bergström S
    Scand J Gastroenterol Suppl; 1982; 77():21-46. PubMed ID: 6750829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The level of endogenous prostaglandins in adolescents with duodenal peptic ulcer in relation to the phase of the disease].
    Isakova MIu
    Lik Sprava; 1998 Aug; (6):49-51. PubMed ID: 9844871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma.
    Wright JP; Young GO; Klaff LJ; Weers LA; Price SK; Marks IN
    Gastroenterology; 1982 Feb; 82(2):263-7. PubMed ID: 7054027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of hepatogenic ulcer].
    Gheorghiu T; Frotz H; Klein HJ
    Schweiz Rundsch Med Prax; 1971 Oct; 60(41):1368-74. PubMed ID: 5141540
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?].
    De Lazzari F; Venturi C; Fregona I; Galliani EA; Bortolami M; Violato D; Floreani AR; Plebani M; Naccarato R
    Minerva Gastroenterol Dietol; 1994 Mar; 40(1):1-9. PubMed ID: 8204699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins in peptic ulcer disease: effect of nonsteroidal anti-inflammatory compounds (NOSAC).
    Konturek SJ; Kwiecień N; Obtułowicz W; Oleksy J; Sito E; Kopp B
    Scand J Gastroenterol Suppl; 1984; 92():250-4. PubMed ID: 6588526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotonin in ulcer disease (literature survey)].
    Frenkel ID; Komissarova IV
    Ter Arkh; 1975; 47(2):142-6. PubMed ID: 49935
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative determination of prostaglandin levels in human gastric mucosa--analysis by microcolumn high performance liquid chromatography with laser induced fluorescence detection.
    Goto H; Sugiyama S; Kawabe Y; Kuroiwa M; Ohara A; Tsukamoto Y; Nakazawa S; Ozawa T
    Biochem Int; 1990; 20(6):1119-25. PubMed ID: 2369414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology of peptic ulcer.
    Crean GP
    Practitioner; 1974 Jul; 213(1273):27-36. PubMed ID: 4614254
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peptic ulcer in liver cirrhosis].
    Giacobbe A; Facciorusso D; Conoscitore P; Spirito F; Nardella GL; Cattani L; Lawson F
    Minerva Dietol Gastroenterol; 1990; 36(4):223-6. PubMed ID: 2089287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of prostaglandins in gastric mucosa of patients with peptic ulcer disease: effect of nonsteroidal antiinflammatory compounds.
    Konturek SJ; Obtulowicz W; Kwiecien N; Oleksy J
    Scand J Gastroenterol Suppl; 1984; 101():75-7. PubMed ID: 6599541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukotriene B4 in gastritis and peptic ulcer].
    Martin A; Sturniolo GC; Fochesato M; Giacomin D; Di Mario F; Arslan P; Naccarato R
    Minerva Gastroenterol Dietol; 1991; 37(3):163-7. PubMed ID: 1665079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
    Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
    Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of aggressive and protective factors in erosive lesions of gastroduodenal mucosa].
    Belova EV; Vakhrushev IaM
    Ter Arkh; 2002; 74(2):17-20. PubMed ID: 11899816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the pathogenesis of primary and secondary stomach ulcers].
    Mosin VI; Ermolaeva NIu; Pasechnikov VD
    Ter Arkh; 1988; 60(2):11-5. PubMed ID: 3368852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggressive factor in the etiology of peptic ulcer--gastric acid secretion].
    Manabe T; Kii E; Tanaka Y; Tobe T
    Nihon Rinsho; 1984 Jan; 42(1):60-6. PubMed ID: 6371309
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostaglandin and cyclic nucleotide levels in patients with peptic ulcer and chronic gastritis with secretory insufficiency].
    Valenkevich LN; Zaĭchuk ASh
    Ter Arkh; 1987; 59(2):29-31. PubMed ID: 3472366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of selective proximal vagotomy on the content of prostaglandins and cyclic nucleotides of the blood and of the gastric mucosa].
    Valenkevich LN
    Lik Sprava; 1995; (9-12):55-7. PubMed ID: 8983792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.